Mark Oliveira

Title: The Innovative Mind of Mark Oliveira: A Pioneer in Pharmaceutical Advancements

Introduction

Mark Oliveira is a notable inventor based in Framingham, MA, renowned for his contributions to the pharmaceutical field. With a remarkable portfolio of six patents, Oliveira has established himself as an influential figure in the development of innovative pharmaceutical compositions.

Latest Patents

Among Oliveira's recent patents are significant advancements in modafinil compositions. These patents focus on polymorphs and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil, which are essential for treating various conditions, including narcolepsy. Another notable patent involves pharmaceutical compositions with improved dissolution. This invention describes methodologies for screening mixtures containing a pharmaceutical compound and an excipient to identify properties that prevent solid-state nucleation. Furthermore, it aims to enhance the solubility, dissolution, and bioavailability of drugs with low solubility in gastric fluids by utilizing a precipitation retardant and optional enhancers.

Career Highlights

Throughout his career, Mark Oliveira has worked with distinguished companies such as Cephalon, Inc. and Transform Pharmaceuticals, Inc. His efforts in these prominent organizations have played a crucial role in advancing pharmaceutical technologies and creating novel drug formulations.

Collaborations

Oliveira’s journey is complemented by collaborations with talented individuals like Matthew Lynn Peterson and Magali Bourghol Hickey. Working alongside such co-inventors has furthered his capacity to innovate and produce high-quality pharmaceutical solutions.

Conclusion

Mark Oliveira's innovative spirit and dedication to enhancing pharmaceutical compositions have made him a key inventor in the industry. His patented inventions not only improve the treatment of conditions like narcolepsy but also pave the way for future advancements in drug formulations. Oliveira’s work exemplifies the critical intersection of science and innovation, marking him as a noteworthy figure in the world of pharmaceuticals.